BIOFLOW-III UK Satellite Registry Orsiro Stent System
NCT02257710 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2017-10-02
Summary
Clinical evaluation of the Orsiro LESS in subjects requiring coronary revascularization with Drug Eluting Stents (DES). 500 subjects will be enrolled in this registry.
Conditions
- Coronary Artery Diseases
Interventions
- DEVICE
-
Orsiro
Sponsors & Collaborators
-
Biotronik UK Ltd.
lead INDUSTRY
Principal Investigators
-
Michael Mahmoudi, MD · St. Peter's Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-11-30
- Primary Completion
- 2018-12-31
- Completion
- 2018-12-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Bioflow-DAPT Study
NCT04137510 ·Status: COMPLETED ·Phase: PHASE4
-
CRUZ Tunisia-Multivessel Registry
NCT06663696 ·Status: RECRUITING
-
BIOFREEDOM Stent Versus ORSIRO Stent: SORT OUT IX
NCT02623140 ·Status: UNKNOWN ·Phase: PHASE4
-
Sirolimus-Eluting BX VELOCITYTM Balloon-Expandable Stent in a Compassionate Use Registry (SECURE)
NCT00231244 ·Status: COMPLETED ·Phase: PHASE3
-
PERVIDEO I Registry, The Lutonix Paclitaxel-Coated Balloon Catheter for the Treatment of Coronary In-Stent Restenosis
NCT00916279 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The BRIDGE Registry: Safety and Efficacy Registry of Bx Cypher Stent
NCT00232804 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the SMART Stent in the Treatment SFA Disease.
NCT00232869 ·Status: COMPLETED ·Phase: PHASE2
-
BioFreedom™ BA9™ Ultra
NCT05331547 ·Status: UNKNOWN
-
Post-Market Clinical Follow-Up of S.M.A.R.T. Family of Stents in Treating Iliac and Femoropopliteal Artery Disease
NCT07338890 ·Status: NOT_YET_RECRUITING
-
A Prospective Study of the Performance of the Bard® LifeStent® Vascular Stent Systems (REALITY)
NCT01920308 ·Status: COMPLETED
-
An Observational Registry Using Drug Eluting Stents (DES) in Patients in a Real-World Setting (DEScover Registry).
NCT00489320 ·Status: COMPLETED
-
The Study to Compare the Cordis SMART™ Stent System With the Bard® Luminexx™ Stent
NCT00235131 ·Status: COMPLETED ·Phase: PHASE4
-
e-BioMatrix PostMarket Registry
NCT01289002 ·Status: COMPLETED
-
Sentinel Low Risk Registry
NCT04131127 ·Status: COMPLETED
-
Aortic-Stent-Register
NCT01197651 ·Status: COMPLETED
-
BioFreedom French Registry
NCT03745066 ·Status: UNKNOWN
-
Safety and Feasibility of the Injectable BL-1040 Implant
NCT00557531 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Over and Under/Aneugraft Pericardium Covered Stent Long Term Follow up Registry
NCT01307553 ·Status: UNKNOWN
-
A Prospective, Single-arm, Multi-centre, Observational, Real World Registry
NCT02901353 ·Status: UNKNOWN
-
Bard® LifeStent® Vascular Stent Delivery System Study
NCT01179984 ·Status: COMPLETED ·Phase: NA
-
Prospective and Non-randomized Registry of CardioCel 3D
NCT04175327 ·Status: ACTIVE_NOT_RECRUITING
-
RESOLUTE International Registry: Evaluation of the Resolute Zotarolimus-Eluting Stent System in a 'Real-World' Patient Population
NCT00752128 ·Status: COMPLETED
-
Pre-market Study of the DREAMS 2G Drug Eluting Absorbable Metal Scaffold (BIOSOLVE-III)
NCT02716220 ·Status: COMPLETED ·Phase: NA
-
The Study to Compare SMART Nitinol Stent and Balloon Angioplasty
NCT00309595 ·Status: COMPLETED ·Phase: PHASE4
-
Adapt Monorail Carotid Stent System: A Postmarket Clinical Follow-up Study
NCT01133327 ·Status: COMPLETED ·Phase: NA